The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 361:1315-1316 September 24, 2009 Number 13
NextNext

Case 19-2009: Carcinoma of the Gastroesophageal Junction

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Kwak, E. L.
-PubMed Citation
To the Editor: In the Case Record of a 63-year-old woman with carcinoma of the gastroesophageal junction, Kwak et al. (June 18 issue)1 provide an excellent overview of the available evidence-based perioperative treatment options, including adjuvant chemoradiation, neoadjuvant chemoradiation, and perioperative chemotherapy. These therapies have never been directly compared and therefore are all reasonable treatment options.2,3,4 The authors are to be complimented for reaching out in their effort to provide guidance in selecting the optimal treatment approach in particular subgroups of patients (personalized medicine). However, we do not understand why they eventually treated the described patient with both perioperative chemotherapy . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.